ArticleJournal of clinical medicine2021

Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients.

Heinz-Peter Schultheiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.